Frangula purshiana bark

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Generic Name
Frangula purshiana bark
DrugBank Accession Number
DB15478
Background

Not Available

Type
Biotech
Groups
Approved, Experimental
Synonyms
  • Aromatic cascara fluidextract
  • Aromatic cascara sagrada fluid extract
  • Bearberry bark
  • Carscara bitterless extract
  • Cascara bitterless bark extract
  • Cascara buckthorn bark
  • Cascara fluidextract, aromatic
  • Cascara sagrada
  • Cascara sagrada bark
  • Cascara sagrada extract
  • Cascara sagrada fluidextract
  • Chittambark
  • Chittem bark
  • Frangula purshiana bark
  • Frangula purshiana bark extract
  • Pursh's buckthorn bark
  • Rhamni purshianae cortex
  • Rhamnus purshiana
  • Rhamnus purshiana bark
  • Rhamnus purshiana bark dry extract
  • Rhamnus purshiana bark extract
  • Rhamnus purshiana stem bark
  • Sacred bark
External IDs
  • B2340
  • Fema no. 2253

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Associated Conditions
Indication TypeIndicationCombined Product DetailsApproval LevelAge GroupPatient CharacteristicsDose Form
Used in combination to treatConstipationCombination Product in combination with: Boldo leaf extract (DB15815)••• ••••••••
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
AcetazolamideThe risk or severity of dehydration can be increased when Acetazolamide is combined with Frangula purshiana bark.
AclidiniumThe therapeutic efficacy of Frangula purshiana bark can be decreased when used in combination with Aclidinium.
AlfentanilThe therapeutic efficacy of Frangula purshiana bark can be decreased when used in combination with Alfentanil.
AmantadineThe therapeutic efficacy of Frangula purshiana bark can be decreased when used in combination with Amantadine.
AmilorideThe risk or severity of dehydration can be increased when Amiloride is combined with Frangula purshiana bark.
Food Interactions
Not Available

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Over the Counter Products
NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImage
Aromatic Cascara Sagrada CompoundLiquid1 g / mLOralD.C. Labs Limited1951-12-312003-07-11Canada flag
Biofant - 41mg/5mlLiquid41 mg / 5 mLOralLes Laboratoires Vachon Inc.1995-12-311997-08-08Canada flag
Cascara AromaticLiquid5 g / 10 mLOralIngram And Bell Inc.1953-12-311999-08-05Canada flag
Cascara Aromatic Liq 250mgLiquid250 mg / mLOralDawson Traders Ltd.1977-12-312006-03-22Canada flag
Cascara Aromatique ElixirLiquid33.3 g / 100 mLOralLab Valmo EnregistrÉ, Division Of Technilab Inc.1983-12-311999-09-17Canada flag
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
Aid-lax TabFrangula purshiana bark (30 mg / tab) + Alloin (12 mg / tab) + Phenolphthalein (100 mg / tab) + Sodium taurocholate (60 mg / tab)TabletOralNobel Pharm Enr.1989-12-311997-07-31Canada flag
AlsilineFrangula purshiana bark (30 mg / tab) + Alloin (12 mg / tab) + Phenolphthalein (100 mg / tab) + Sodium taurocholate (60 mg / tab)TabletOralAlsi Cie Ltee1978-12-311997-08-08Canada flag
AMARO MEDICINALE GIULIANIFrangula purshiana bark (121 mg/100g) + Boldo leaf extract (100 mg/100g) + Gentian violet cation (111 mg/100g) + Rhubarb (356 mg/100g)SolutionOralGiuliani Spa2014-07-08Not applicableItaly flag
AMARO MEDICINALE GIULIANIFrangula purshiana bark (121 mg/100g) + Boldo leaf extract (100 mg/100g) + Gentian violet cation (111 mg/100g) + Rhubarb (356 mg/100g)SolutionOralGiuliani Spa2014-07-08Not applicableItaly flag
AMARO MEDICINALE GIULIANIFrangula purshiana bark (121 mg/100g) + Boldo leaf extract (100 mg/100g) + Gentian violet cation (111 mg/100g) + Rhubarb (356 mg/100g)SolutionOralGiuliani Spa2014-07-08Not applicableItaly flag

Categories

Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
4VBP01X99F
CAS number
8015-89-2

References

General References
Not Available
RxNav
1350209

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
SolutionOral
Powder, for solutionOral
Powder, for suspensionOral
LiquidOral41 mg / 5 mL
PowderNot applicable1 kg/1kg
LiquidOral5 g / 10 mL
LiquidOral250 mg / mL
LiquidOral33.3 g / 100 mL
LiquidOral
CapsuleOral400 mg / cap
CapsuleOral450 mg / cap
CapsuleOral100 mg / cap
CapsuleOral500 mg / cap
CapsuleOral400 mg / tab
Capsule, coatedOral400 mg
TabletOral487.5 mg
TabletOral324 mg / tab
TabletOral325 mg
Tablet, coatedOral
SyrupOral
CapsuleOral80.5 mg / cap
LiquidOral325 mg / 30 mL
KitOral
TabletOral
LiquidOral1 g / mL
TabletOral200 mg / tab
TabletOral160 mg / tab
LiquidOral
CapsuleOral
TabletOral330 mg / tab
LiquidOral1.1664 g / 30 mL
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Drug created at August 30, 2019 15:40 / Updated at October 02, 2020 07:51